Here is what you’ll find in this week’s newsletter!

1. Important links 🔗 - the best articles we found this week about the Medicare Market along with links to Jared’s recent LinkedIn posts.

2. Deep Dive 📚 - Elevance Pulls Back on Marketing Medicare Advantage Plans 🌦️

3. Sponsor Snapshot 🚀 - brought to you by Modivcare

4. Compliance Chatter 📢 - Several new regulations to review!

It’s only a 5 minute read, but it will make you 10x smarter.

DEEP DIVE 📚

Elevance Pulls Back on Marketing Medicare Advantage Plans 🌦️

Shortly after UnitedHealth Group’s disappointing quarterly release (more on that here), Elevance ($ELV ( ▲ 1.68% ) ) reported Q1 results—delivering solid growth and hitting expectations.

They grew MA membership by 11.8%, Revenues by 15.4% and Operating Profit by 5.1%.

See my LinkedIn post on ELV Q1 results here → (link)

On Medicare Advantage, here is what they said in their Earnings Call:

If you googled Elevance the days that followed, here is what you would have found:

So, all is well, right? Well, maybe not…

Late last week I saw this pop up on LinkedIn.

It quickly became the dominant topic across the Medicare ecosystem. It sounds like the plans remain available, and commissions will still be paid—but agents must now submit applications manually.

AgentBoost discussed it in their recent podcast (listen here).

And there are several articles on the topic (here, here).

It’s clear, that Elevance continues to be concerned with adding to much new MA membership onto their current plans. They already stopped paying commission on certain plans mid AEP.

Now they are effectively cutting off new sales for the rest of the year (likely until new plans are developed for 2026).

What's Behind the Decision?

Elevance’s recent move has raised questions across the industry. While the company hasn’t shared detailed public reasoning, several experts point to operational and financial stress from faster-than-expected membership growth as likely drivers.

John Selby, President of Rebellis Group, believes the decision is a response to capacity challenges and risk management concerns:

Selby adds that this could signal a broader trend heading into 2026:

That concern around new-to-Medicare enrollees was echoed by Roshan Desai, VP of Product and Financial Strategy at Rebellis, who noted that lower initial risk scores translate into higher medical loss ratios (MLRs):

Desai also raised another possible factor: commission structure. With most enrollees now being new to MA, Elevance would be paying the full first-year commission rather than a pro-rated or renewal rate—raising acquisition costs at a time when member profitability is already under pressure.

Bottom line: Elevance grew enrollment significantly during AEP—but they appear uninterested in further growing non-D-SNP membership for the remainder of the year.

—

Recent Enrollment Trends

As discussed in our AEP breakdown (link), Elevance grew MA enrollment by 12% during AEP. Up 240,000.

__

The AEP growth was a mix of Employer Group, Individual Non SNP and SNP.

Based on the messaging, Elevance seems comfortable with their D-SNP growth, but is pulling back on Individual Non-SNP and likely C-SNP as well.

Looking at enrollment for Individual Non-SNP and C-SNP combined we can see the large AEP increase, with a decrease in enrollment since.

So, there’s no evidence of a post-AEP enrollment surge, but they must be concerned nonetheless.

—

State Impacts

There are some states that may be impacted by this move more than others.

Looking at Elevance’s AEP enrollment growth by state, reveals that in Indiana, Virginia, and Wisconsin they outpaced competitor growth by a lot.

📽️Elevance AEP Growth - IN, VA, WI (watch video clip)

This indicates they have especially attractive plans in those states.

Going forward, consumers and agents will have a harder time applying for plans in these (and all other) states!

—

Final Thoughts

Elevance’s decision to pause new MA sales isn’t a reaction to poor Q1 results—it’s a strategic recalibration.

After an aggressive AEP with strong growth, the company appears to be prioritizing operational stability and margin over continued near-term expansion.

This move reflects broader pressure facing MA carriers in 2025. It’s also a signal to watch heading into 2026. If Elevance is pulling back, other regional and local carriers may follow suit.

That said, cutting off new applications midyear—even if technically still available through manual submission—risks chipping away at the goodwill they’ve built with agents and brokers. Distribution partners value consistency and clarity, and sudden shifts like this make it harder to plan, sell, and serve clients.

For distributors and agents, it’s a reminder that even top-performing plans can pivot fast—and those decisions ripple downstream quickly.

__

If you’re ready, here are some ways we can help you:

• Newsletter Sponsorship opportunities: Promote your product or services to leaders in the Medicare space. Let’s discuss. (link)

• Market Research: Reports that help you wrap your arms around the Senior focused insurance markets. (link)

• Consulting: We can help you develop new insurance products for the Medicare market, appraise your books of business, and keep you compliant. Let’s discuss. (link)